CHRISTINA TREMBLAY: Open Payments
NPI 1003325648 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 38 payments from 11 companies in 2025. Trend: 2023 $1,198 · 2024 $1,161 · 2025 $1,546
Food & beverage: $1,546
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $290 |
| ABBVIE INC. | 5 | $275 |
| Organogenesis Inc. | 4 | $257 |
| Arcutis Biotherapeutics, Inc. | 4 | $190 |
| GENZYME CORPORATION | 2 | $163 |
| Galderma Laboratories, L.P. | 1 | $125 |
| Incyte Corporation | 3 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Zoryve, AFFINITY, NEMLUVIO, OPZELURA, BOTOX.
Industry payments across FL — which companies pay providers there.
